Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recent studies show that
oxytocin
has various effects on cellular behaviors.
Oxytocin
is reported to stimulate cardiomyogenesis of embryonic stem cells and endothelial cell proliferation. Mesenchymal stem cells (MSCs) are widely used for cardiac repair, and we elucidated the effect of
oxytocin
on umbilical cord derived-MSCs (UCB-MSCs). UCB-MSCs were pretreated with
oxytocin
(100 nM) and washed with saline prior to experiments. To evaluate their angiogenic potential and migration activity, tube formation assay and Boyden chamber assay were performed. For in vivo study, ischemia-reperfusion was induced in rats, and UCB-MSCs with or without
oxytocin
pretreatment were injected into the infarcted myocardium to evaluate the engraftment of injected cells. Histological and hemodynamic studies were performed.
Oxytocin
-treated UCB-MSCs showed a decrease in tube formation but a drastic increase in transwell migration activity. The transcription level of matrix metalloproteinase (MMP)-2 was increased in
oxytocin
-treated UCB-MSCs. Knock-down of MMP-2 by use of siRNA restored the tube formation, while reducing transmigration activity. In rats injected with
oxytocin
-treated UCB-MSCs, cardiac fibrosis and
CD68
infiltration in the peri-infarct zone were reduced, whereas cell engraftment and connexin43 expression were greater than in rats injected with untreated UCB-MSCs. By contrast, angiogenesis did not differ significantly between the two groups. Cardiac contractility was higher in the group injected with
oxytocin
-treated UCB-MSCs than in the group injected with phosphate-buffered saline alone. Collectively,
oxytocin
is an effective priming reagent for stem cells for application to damaged heart tissue.
...
PMID:Promigratory activity of oxytocin on umbilical cord blood-derived mesenchymal stem cells. 2062 60
Neuropeptides including
oxytocin
belong to the group of factors that may play a role in the control of neuronal cell survival, proliferation and differentiation. The aim of the present study was to investigate potential contribution of
oxytocin
to neuronal differentiation by measuring gene and protein expression of specific neuron and glial markers in the brain. Neonatal and adult
oxytocin
administration was used to reveal developmental and/or acute effects of
oxytocin
in Wistar rats. Gene and protein expression of neuron-specific enolase (NSE) in the hippocampus was increased in 21-day and 2-month old rats in response to neonatal
oxytocin
administration. Neonatal
oxytocin
treatment induced a significant increase of gene and protein expression of the marker of astrocytes - glial fibrillary acid protein (GFAP).
Oxytocin
treatment resulted in a decrease of oligodendrocyte marker mRNA - 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) - in 21-day and 2-month old rats, while no change of
CD68
mRNA, marker of microglia, was observed. Central
oxytocin
administration in adult rats induced a significant increase of gene expression of NSE and CNPase. The present study provides the first data revealing the effect of
oxytocin
on the expression of neuron and glial markers in the brain. It may be suggested that the
oxytocin
system is involved in the regulation of development of neuronal precursor cells in the brain.
...
PMID:Oxytocin Modulates Expression of Neuron and Glial Markers in the Rat Hippocampus. 2880 58